DALESSANDRO, MARGHERITA
DALESSANDRO, MARGHERITA
Acute urinary retention due to HSV-1: a case report
2009-01-01 Mancino, Paola; Dalessandro, Margherita; Falasca, Katia; Ucciferri, Claudio; Pizzigallo, Eligio; Vecchiet, Jacopo
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy
2004-01-01 Dalessandro, Margherita; Falasca, Katia; Racciatti, Delia; Zingariello, Pompea; Cacciatore, P; Travasi, F; Scarinci, A; Ceccomancini, A; Di Giammarco, A; Pizzigallo, Eligio; Vecchiet, Jacopo
Economic evaluation on HIV treatments: The I.Co.N.A. cohort study.
2005-01-01 Merito, M; Bonaccorsi, A; Pammolli, F; Pastore, G; for the ICONA Study, Group; Pizzigallo, Eligio; Dalessandro, Margherita
Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.
2006-01-01 Solmone, M; Girardi, E; Lalle, E; Capobianchi MR for the HepaICONA, . .; the ICONA Study, Group; Pizzigallo, Eligio; Dalessandro, Margherita
Interruption of highly active antiretroviral therpy in HIV clinical practice.
2005-01-01 d'Arminio Monforte, A; Cozzi Lepri, A; Phillips, A; Moroni, M; for the Italian Cohort of Antiretroviral Naive Pathients Study, Group; Pizzigallo, Eligio; Dalessandro, Margherita
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors.
2006-01-01 Svicher, V; Sing, T; Santoro, Mm; Perno CF, . .; Pizzigallo, Eligio; Dalessandro, Margherita
Is moderate HIV-viremia associated with a higher risk of clinical progression in HIV-infected people treated with high active antiretroviral therapy.
2006-01-01 Murri, R; Cozzi Lepri, A; Cicconi, P; d'Arminio Monforte A, . .; Study Group, for the I. C. o. N. A.; Pizzigallo, Eligio; Dalessandro, Margherita
Metabolic modifications in HIV-infected women
2004-01-01 Vecchiet, J.; Falasca, K.; Zingariello, P.; Travasi, F.; Manigrasso, M. R.; Di Ilio, E.; Dalessandro, M.; Capani, F.; Paganelli, R.; Pizzigallo, E.; Guagnano, M. T.
Mortality from HIV and TB coinfections in higher in Eastern Europe than in Western Europe and Argentina.
2009-01-01 Podiekareva, Dn; Mocroft, A; Post, Fa; Riekstina, V; Miro, Jm; Furrer, H; Bruyand, M; Panteleev, Am; Rakhmanova, Ag; Girardi, E; Losso, Mh; Toibaro, Jj; Cayalà, J; Miller, Rf; Obel N., Skrahina A; Chentsova, N; Lundgren, Jd; Kirk, O; HIV/TB Study Writing, G. r. o. u. p. .; Pizzigallo, Eligio; Dalessandro, Margherita
Predictability of sustained virological response to pegylate interferon alpha-2b plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C infection.
2009-01-01 Angeli, E; Mainini, A; Cargel, A; Uberti Foppa, C; Orani, A; Carbone, R; Andreoni, M; Schiavini, M; Giorgi, R; Rizzardini, G; Gubertini, G; Icos, 2 Group; Pizzigallo, Eligio; Dalessandro, Margherita
Risk of developing specific AIDS-defining illness in patients coinfected with HIV and hepatitis C virus with or without cirrhosis.
2009-01-01 d'Arminio Monforte, A; Cozzi Lepri, A; Castagna, A; Antinori, A; De Luca, A; Mussini, C; Caputo, Sl; Arlotti, M; Magnani, G; Pellizzer, G; Maggiolo, F; Puoti, M; Icona Foundation Study, Group; Pizzigallo, Eligio; Dalessandro, Margherita
Study of immune alterations in patients with Chronic Fatigue Sindrome with different etiologies
2004-01-01 Racciatti, Delia; Dalessandro, Margherita; Delle Donne, L; Falasca, Katia; Zingariello, Pompea; Paganelli, Roberto; Pizzigallo, E; Vecchiet, Jacopo
Viral interference between hepatitis B, C and D viruses in dual and triple infections in HIV-positive patients.
2009-01-01 Morsica, G; Bagaglio, S; Cicconi, P; Capobianchi, Mr; Pellizzer, G; Caramello, P; Orani, A; Maioli, C; Rizzardini, G; Uberti Foppa, C; Puoti, M; HepaICoNa the Icona Foundation Study, Groups; Pizzigallo, Eligio; Dalessandro, Margherita
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Acute urinary retention due to HSV-1: a case report | 2009 | Mancino, Paola; Dalessandro, Margherita; Falasca, Katia; Ucciferri, Claudio; Pizzigallo, Eligio; Vecchiet, Jacopo | |
| Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy | 2004 | Dalessandro, Margherita; Falasca, Katia; Racciatti, Delia; Zingariello, Pompea; Cacciatore, P; Travasi, F; Scarinci, A; Ceccomancini, A; Di Giammarco, A; Pizzigallo, Eligio; Vecchiet, Jacopo | |
| Economic evaluation on HIV treatments: The I.Co.N.A. cohort study. | 2005 | Merito, M; Bonaccorsi, A; Pammolli, F; Pastore, G; for the ICONA Study, Group; Pizzigallo, Eligio; Dalessandro, Margherita | |
| Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy. | 2006 | Solmone, M; Girardi, E; Lalle, E; Capobianchi MR for the HepaICONA, . .; the ICONA Study, Group; Pizzigallo, Eligio; Dalessandro, Margherita | |
| Interruption of highly active antiretroviral therpy in HIV clinical practice. | 2005 | d'Arminio Monforte, A; Cozzi Lepri, A; Phillips, A; Moroni, M; for the Italian Cohort of Antiretroviral Naive Pathients Study, Group; Pizzigallo, Eligio; Dalessandro, Margherita | |
| Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. | 2006 | Svicher, V; Sing, T; Santoro, Mm; Perno CF, . .; Pizzigallo, Eligio; Dalessandro, Margherita | |
| Is moderate HIV-viremia associated with a higher risk of clinical progression in HIV-infected people treated with high active antiretroviral therapy. | 2006 | Murri, R; Cozzi Lepri, A; Cicconi, P; d'Arminio Monforte A, . .; Study Group, for the I. C. o. N. A.; Pizzigallo, Eligio; Dalessandro, Margherita | |
| Metabolic modifications in HIV-infected women | 2004 | Vecchiet, J.; Falasca, K.; Zingariello, P.; Travasi, F.; Manigrasso, M. R.; Di Ilio, E.; Dalessandro, M.; Capani, F.; Paganelli, R.; Pizzigallo, E.; Guagnano, M. T. | |
| Mortality from HIV and TB coinfections in higher in Eastern Europe than in Western Europe and Argentina. | 2009 | Podiekareva, Dn; Mocroft, A; Post, Fa; Riekstina, V; Miro, Jm; Furrer, H; Bruyand, M; Panteleev, Am; Rakhmanova, Ag; Girardi, E; Losso, Mh; Toibaro, Jj; Cayalà, J; Miller, Rf; Obel N., Skrahina A; Chentsova, N; Lundgren, Jd; Kirk, O; HIV/TB Study Writing, G. r. o. u. p. .; Pizzigallo, Eligio; Dalessandro, Margherita | |
| Predictability of sustained virological response to pegylate interferon alpha-2b plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C infection. | 2009 | Angeli, E; Mainini, A; Cargel, A; Uberti Foppa, C; Orani, A; Carbone, R; Andreoni, M; Schiavini, M; Giorgi, R; Rizzardini, G; Gubertini, G; Icos, 2 Group; Pizzigallo, Eligio; Dalessandro, Margherita | |
| Risk of developing specific AIDS-defining illness in patients coinfected with HIV and hepatitis C virus with or without cirrhosis. | 2009 | d'Arminio Monforte, A; Cozzi Lepri, A; Castagna, A; Antinori, A; De Luca, A; Mussini, C; Caputo, Sl; Arlotti, M; Magnani, G; Pellizzer, G; Maggiolo, F; Puoti, M; Icona Foundation Study, Group; Pizzigallo, Eligio; Dalessandro, Margherita | |
| Study of immune alterations in patients with Chronic Fatigue Sindrome with different etiologies | 2004 | Racciatti, Delia; Dalessandro, Margherita; Delle Donne, L; Falasca, Katia; Zingariello, Pompea; Paganelli, Roberto; Pizzigallo, E; Vecchiet, Jacopo | |
| Viral interference between hepatitis B, C and D viruses in dual and triple infections in HIV-positive patients. | 2009 | Morsica, G; Bagaglio, S; Cicconi, P; Capobianchi, Mr; Pellizzer, G; Caramello, P; Orani, A; Maioli, C; Rizzardini, G; Uberti Foppa, C; Puoti, M; HepaICoNa the Icona Foundation Study, Groups; Pizzigallo, Eligio; Dalessandro, Margherita |